Goldman Sachs Group Inc
Change company Symbol lookup
Select an option...
GS Goldman Sachs Group Inc
ONON On Holding AG
XNCR Xencor Inc
ALT Altimmune Inc
RZLT Rezolute Inc
BNKU MicroSectors? U.S. Big Banks Index 3X Leveraged ETNs
SGFY Signify Health Inc
FRC First Republic Bank
BACK IMAC Holdings Inc
LYLT Loyalty Ventures Inc
Go

Financials : Capital Markets | Large Cap Value
Company profile

The Goldman Sachs Group, Inc. is a global financial institution that delivers a range of financial services across investment banking, securities, investment management and consumer banking to a diversified client base that includes corporations, financial institutions, governments and individuals. The Company segments include Global Banking & Markets, Asset & Wealth Management and Platform Solutions. The Global Banking & Markets segment includes financing, advisory services, risk distribution, and hedging for its institutional and corporate clients, including Fixed Income, Currency and Commodities (FICC) and Equities, Investment Banking and Marquee. The Asset & Wealth Management segment includes advice, investing, and execution for institutions and individuals across public and private markets. The Platform Solutions segment includes consumer platforms, such as partnerships offering credit cards and point-of-sale financing, and transaction banking and other platform businesses.

Price
Delayed
$318.55
Day's Change
9.02 (2.91%)
Bid
--
Ask
--
B/A Size
--
Day's High
320.32
Day's Low
315.35
Volume
(Light)

Today's volume of 1,572,794 shares is on pace to be much lighter than GS's 10-day average volume of 4,214,926 shares.

1,572,794

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023

5:45 am ET January 23, 2023 (PR Newswire) Print

Attention NeoGenomics, Inc. ("NeoGenomics") (NASDAQ: NEO) shareholders:

The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between February 27, 2020 and April 26, 2022.

If you suffered a loss on your investment in NeoGenomics, contact us about potential recovery by using the link below. There is no cost or obligation to you.

https://www.wongesq.com/pslra-1/neogenomics-class-action-loss-submission-form?prid=35806&wire=4

ABOUT THE ACTION: The class action against NeoGenomics includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) defendants represented to investors that it had a "comprehensive menu" of cancer tests with "every kind of testing modality that you can use for cancer, including some of the fast-growing new ones, like next-generation sequencing," which positioned the Company as a "one-stop-shop" for pathologists and gave NeoGenomics "a competitive advantage" as a "go-to reference lab with a comprehensive menu for just about any kind of tests that you want to have done in cancer"; and (2) defendants represented that NeoGenomics could "leverage" the supposedly "fixed cost" structure of its business to improve profitability as revenue increased and touted the Company's "robust Compliance Program . . . to ensure compliance with the myriad of . . . laws, regulations and governmental guidance applicable to our business."

DEADLINE: February 6, 2023

Aggrieved NeoGenomics investors only have until February 6, 2023 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY 10002Tel. 212.425.1140E-Mail: vw@wongesq.com

https://c212.net/c/img/favicon.png?sn=NY93120&sd=2023-01-23

View original content:https://www.prnewswire.com/news-releases/class-action-alert-the-law-offices-of-vincent-wong-remind-neogenomics-investors-of-a-lead-plaintiff-deadline-of-february-6-2023-301727453.html

SOURCE The Law Offices of Vincent Wong

https://rt.newswire.ca/rt.gif?NewsItemId=NY93120&Transmission_Id=202301230545PR_NEWS_USPR_____NY93120&DateId=20230123

comtex tracking

COMTEX_423143221/1005/2023-01-23T05:45:11

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.